These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17867489)

  • 1. In vitro activity of cefotiam against oxacillin-resistant Staphylococcus epidermidis strains--reevaluation of beta-lactam antibiotics efficiency on MRSE.
    Nakamura A; Oguri T; Misawa S; Tabe Y; Kondo S; Miyake K; Miyake N; Igari J; Ohsaka A
    Jpn J Antibiot; 2007 Jun; 60(3):153-60. PubMed ID: 17867489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of PBP2' by antibiotics and disinfectants in MRSE].
    Hen K; Imafuku Y; Yoshida H
    Rinsho Byori; 2008 Nov; 56(11):955-60. PubMed ID: 19086449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic Branched Polyethylenimine (BPEI) Disables Antibiotic Resistance in Methicillin-Resistant Staphylococcus epidermidis (MRSE).
    Lam AK; Hill MA; Moen EL; Pusavat J; Wouters CL; Rice CV
    ChemMedChem; 2018 Oct; 13(20):2240-2248. PubMed ID: 30193012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. I. Cefotiam plus minocycline].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1992 Jun; 45(6):597-604. PubMed ID: 1507393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
    Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
    Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococci isolated from animals and food with phenotypically reduced susceptibility to beta-lactamase-resistant beta-lactam antibiotics.
    Kaszanyitzky EJ; Egyed Z; Jánosi S; Keseru J; Gál Z; Szabó I; Veres Z; Somogyi P
    Acta Vet Hung; 2004; 52(1):7-17. PubMed ID: 15119783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    Hara T; Araake M; Tsuruoka T; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)].
    Shimada K; Nakano K; Igari J; Oguri T; Ikemoto H; Mori T; Yokouchi H; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Okada S; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Nakata K; Nakatani T; Inagawa H; Kudo K; Kobayashi N; Tanaka T; Kobayashi H; Goto H; Kawai S; Takeda H; Sumitomo M; Matsushima T; Niki Y; Kohno S; Miyazaki Y; Yanagihara K; Hirakata Y; Matsuda J; Nasu M; Hiramatsu K; Suga M; Tosaka M
    Jpn J Antibiot; 2004 Jun; 57(3):213-45. PubMed ID: 15376784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic expression of oxacillin resistance in Staphylococcus epidermidis: roles of mecA transcriptional regulation and resistant-subpopulation selection.
    Dickinson TM; Archer GL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1616-23. PubMed ID: 10817718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms.
    Sharafi T; Ghaemi EA; Rafiee M; Ardebili A
    Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):7. PubMed ID: 38245727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of eight antibiotics against methicillin-resistant S. aureus and S. epidermidis strains isolated in Korea.
    Chang WH; Choi MS; Chung HY; Seo WJ; Choi TY; Chong YS; Kim JS; Chung SS; Hong SH
    J Korean Med Sci; 1988 Jun; 3(2):45-50. PubMed ID: 3267354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates in the Tunisian Bone Marrow Transplant Center.
    Achour W; Bouchami O; Galopin S; Leclercq R; Ben Hassen A
    Lett Appl Microbiol; 2008 Mar; 46(3):358-63. PubMed ID: 18194160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of oxacillin and cefoxitin disk-diffusion method and PCR for the identification methicillin-resistant Staphylococcus epidermidis].
    Budzyńska A; Kaczmarek A; Mikołajczyk D; Gospodarek E
    Med Dosw Mikrobiol; 2007; 59(1):27-33. PubMed ID: 17601028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.
    Kiri N; Archer G; Climo MW
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2017-20. PubMed ID: 12019130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: β-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin.
    Fleer A; Hemels MA; Paauw A; Krediet TG
    J Antimicrob Chemother; 2012 Jul; 67(7):1616-8. PubMed ID: 22438436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of coagulase-negative Staphylococcus species isolated from bovine milk.
    Sawant AA; Gillespie BE; Oliver SP
    Vet Microbiol; 2009 Feb; 134(1-2):73-81. PubMed ID: 18950969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.